For help on how to get the results you want, see our search tips.
1262 results
Medicine
European public assessment reports (EPAR) Remove European public assessment reports (EPAR) filter
Categories
Human Remove Human filter
-
List item
Human medicine European public assessment report (EPAR): Rukobia (updated)
fostemsavir trometamol, HIV Infections
Date of authorisation: 04/02/2021,
, Revision: 1, Authorised, Last updated: 13/04/2021
-
List item
Human medicine European public assessment report (EPAR): Vantobra (previously Tobramycin PARI) (updated)
Tobramycin, Respiratory Tract Infections, Cystic Fibrosis
Date of authorisation: 18/02/2019, Revision: 3, Authorised, Last updated: 13/04/2021 -
List item
Human medicine European public assessment report (EPAR): Vaxzevria (previously COVID-19 Vaccine AstraZeneca) (updated)
ChAdOx1-SARS-COV-2, COVID-19 virus infection
Date of authorisation: 29/01/2021,, 
, Revision: 3, Authorised, Last updated: 13/04/2021
-
List item
Human medicine European public assessment report (EPAR): Deferasirox Mylan (updated)
deferasirox, Iron Overload, beta-Thalassemia
Date of authorisation: 26/09/2019,
, Revision: 4, Authorised, Last updated: 13/04/2021
-
List item
Human medicine European public assessment report (EPAR): Beromun (updated)
tasonermin, Sarcoma
Date of authorisation: 12/04/1999, Revision: 14, Authorised, Last updated: 13/04/2021 -
List item
Human medicine European public assessment report (EPAR): Synagis (updated)
palivizumab, Respiratory Syncytial Virus Infections
Date of authorisation: 13/08/1999, Revision: 42, Authorised, Last updated: 13/04/2021 -
List item
Human medicine European public assessment report (EPAR): Inovelon (updated)
Rufinamide, Epilepsy
Date of authorisation: 16/01/2007, Revision: 21, Authorised, Last updated: 12/04/2021 -
List item
Human medicine European public assessment report (EPAR): Erleada (updated)
apalutamide, Prostatic Neoplasms
Date of authorisation: 14/01/2019,, Revision: 3, Authorised, Last updated: 12/04/2021
-
List item
Human medicine European public assessment report (EPAR): Ixiaro (updated)
Japanese-encephalitis virus, inactivated (attenuated strain SA14-14-2 grown in vero cells), Encephalitis, Japanese, Immunization
Date of authorisation: 31/03/2009, Revision: 17, Authorised, Last updated: 12/04/2021 -
List item
Human medicine European public assessment report (EPAR): Emtricitabine/Tenofovir disoproxil Krka (updated)
emtricitabine, tenofovir disoproxil succinate, HIV Infections
Date of authorisation: 09/12/2016,, Revision: 9, Authorised, Last updated: 09/04/2021
-
List item
Human medicine European public assessment report (EPAR): Zoledronic acid Mylan (updated)
zoledronic acid, Fractures, Bone
Date of authorisation: 23/08/2012,, Revision: 11, Authorised, Last updated: 09/04/2021
-
List item
Human medicine European public assessment report (EPAR): Jentadueto (updated)
linagliptin, metformin, Diabetes Mellitus, Type 2
Date of authorisation: 19/07/2012, Revision: 19, Authorised, Last updated: 09/04/2021 -
List item
Human medicine European public assessment report (EPAR): Coagadex (updated)
Human coagulation factor X, Factor X Deficiency
Date of authorisation: 16/03/2016,, 
, 
, Revision: 7, Authorised, Last updated: 09/04/2021
-
List item
Human medicine European public assessment report (EPAR): Opsumit (updated)
Macitentan, Hypertension, Pulmonary
Date of authorisation: 20/12/2013,, Revision: 17, Authorised, Last updated: 09/04/2021
-
List item
Human medicine European public assessment report (EPAR): Trimbow (updated)
Beclometasone dipropionate, formoterol fumarate dihydrate, glycopyrronium bromide, Pulmonary Disease, Chronic Obstructive
Date of authorisation: 17/07/2017, Revision: 5, Authorised, Last updated: 09/04/2021 -
List item
Human medicine European public assessment report (EPAR): Dovprela (previously Pretomanid FGK) (updated)
Pretomanid, Tuberculosis, Multidrug-Resistant
Date of authorisation: 31/07/2020,, , , Revision: 3, Authorised, Last updated: 09/04/2021
-
List item
Human medicine European public assessment report (EPAR): Ogivri (updated)
trastuzumab, Stomach Neoplasms, Breast Neoplasms
Date of authorisation: 12/12/2018,, 
, Revision: 6, Authorised, Last updated: 09/04/2021
-
List item
Human medicine European public assessment report (EPAR): Lynparza (updated)
Olaparib, Ovarian Neoplasms
Date of authorisation: 16/12/2014, Revision: 13, Authorised, Last updated: 09/04/2021 -
List item
Human medicine European public assessment report (EPAR): Rubraca (updated)
rucaparib camsylate, Ovarian Neoplasms
Date of authorisation: 23/05/2018,, , Revision: 6, Authorised, Last updated: 09/04/2021
-
List item
Human medicine European public assessment report (EPAR): Olanzapine Teva (updated)
olanzapine, Schizophrenia, Bipolar Disorder
Date of authorisation: 12/12/2007,, Revision: 28, Authorised, Last updated: 08/04/2021
-
List item
Human medicine European public assessment report (EPAR): Brineura (updated)
cerliponase alfa, Neuronal Ceroid-Lipofuscinoses
Date of authorisation: 30/05/2017,, , , 
, Revision: 5, Authorised, Last updated: 08/04/2021
-
List item
Human medicine European public assessment report (EPAR): Xromi (updated)
hydroxycarbamide, Anemia, Sickle Cell
Date of authorisation: 01/07/2019, Authorised, Last updated: 08/04/2021 -
List item
Human medicine European public assessment report (EPAR): Efavirenz/Emtricitabine/Tenofovir disoproxil Krka (updated)
efavirenz, emtricitabine, tenofovir disoproxil succinate, HIV Infections
Date of authorisation: 08/02/2018,, Revision: 6, Authorised, Last updated: 08/04/2021
-
List item
Human medicine European public assessment report (EPAR): Pegasys (updated)
peginterferon alfa-2a, Hepatitis C, Chronic, Hepatitis B, Chronic
Date of authorisation: 20/06/2002, Revision: 42, Authorised, Last updated: 08/04/2021 -
List item
Human medicine European public assessment report (EPAR): Lyrica (updated)
pregabalin, Epilepsy, Anxiety Disorders, Neuralgia
Date of authorisation: 05/07/2004, Revision: 49, Authorised, Last updated: 08/04/2021